Yu, B <br/><br/>
Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jun 1996 
 - 1798-809 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1996.14.6.1798  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Carcinoembryonic Antigen--blood<br/>Colorectal Neoplasms--radiotherapy<br/>Dose-Response Relationship, Radiation<br/>Gastrointestinal Neoplasms--diagnostic imaging<br/>Humans<br/>Iodine Radioisotopes--adverse effects<br/>Pancreatic Neoplasms--radiotherapy<br/>Radioimmunotherapy--adverse effects<br/>Radionuclide Imaging<br/>Radiotherapy Dosage<br/>Stomach Neoplasms--radiotherapy